Back
PT Bank Danamon Indonesia Tbk Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
1
PBDIF
PT Bank Danamon Indonesia Tbk
Last Price:
$0.31
Seasonality Move:
0%
Sell
2
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-6.74%
Sell
1
PT Bank Danamon Indonesia Tbk (PBDIF)
is a Sell
Is PT Bank Danamon Indonesia Tbk a Buy, Sell or Hold?
-
The current PT Bank Danamon Indonesia Tbk [PBDIF] share price is $0.31. The Score for PBDIF is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
PBDIF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
2
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
PBDIF Stock Price Chart
What is PT Bank Danamon Indonesia Tbk's stock price today?
-
The PT Bank Danamon Indonesia Tbk share price today is $0.31The current trend is relatively stagnant and PBDIF is experiencing slight buying pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $40.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
PBDIF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Sell |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.31 - 0.31) | Sell |
Bollinger Bands (100): | (0.31 - 0.31) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 22.69 | Sell |
Chaikin Money Flow: | -2576687 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.5 - 57.26) | Sell |
Bollinger Bands (100): | (51.08 - 57.64) | Sell |
PBDIF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.31 | Sell |
20-day SMA: | 0.31 | Sell |
50-day SMA: | 0.31 | Sell |
200-day SMA: | 0.31 | Sell |
8-day EMA: | 0.31 | Sell |
20-day EMA: | 0.31 | Sell |
50-day EMA: | 0.31 | Sell |
200-day EMA: | 0.31 | Sell |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.44 | Sell |
20-day SMA: | 52.35 | Sell |
50-day SMA: | 55.3 | Sell |
200-day SMA: | 51.01 | Sell |
8-day EMA: | 48.54 | Sell |
20-day EMA: | 51.52 | Sell |
50-day EMA: | 53.69 | Sell |
200-day EMA: | 49.87 | Sell |
PT Bank Danamon Indonesia Tbk Earnings Growth & PBDIF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
PT Bank Danamon Indonesia Tbk Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |